NFKB1 and cancer: Previous studies have shown that Withaferin A can effectively induce apoptosis in cancer cells, arrest cell cycle progression [39], and modulate critical signaling pathways such as NF-κB [40], ultimately inhibiting tumor growth and metastasis.